Furthermore, kinase-inactive IRAKM reduced IL-1β-induced de novo fatty acid synthesis in adipocytes, and lipid accumulation in both WAT and BAT from HFD-fed mice to improve obesity-related pathophysiology. Here, IL1B is linked to obesity disorder.